Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review

• Autores principales: Qiang Tong (Autor), Peng-chong Zhu (Autor), Zhuang Zhuang (Autor), Li-hui Deng (Autor), Zi-hao Wang (Autor), Hua Zeng (Autor), Guo-qing Zheng (Autor), Yan Wang (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Notoginsenoside R1 (NGR1) exerts pharmacological actions for a variety of diseases such as myocardial infarction, ischemic stroke, acute renal injury, and intestinal injury. Here, we conducted a preclinical systematic review of NGR1 for ischemia reperfusion (I/R) injury. Eight databases were searche...